Formed in 2000, the rapidly-growing company currently has two tests under development and expects both to enter clinical trials and gain approvals later this year
A wealth of information on Oxford Biosensors is now available on its new website.
Formed in 2000, the rapidly-growing company currently has two tests under development and expects both to enter clinical trials and gain approvals later this year.
The novel biosensor technology at the heart of these rapid tests offers a new platform for the delivery of lab-quality results at the point-of-care.
The easy-to-navigate site covers areas from the development of the Multisense system to news about expansion into new offices with modern production and research facilities. The technical overview section details innovative technology which integrates electrochemistry, microtechnology and biochemistry to offer rapid and accurate detection of target analytes at low cost.
The novelty of the technology lies in the tiny test strips which incorporate micron-sized electrodes using low cost plastic and carbon substrates.
Multiple parameters can be configured on one test strip, allowing the detection and monitoring of medical conditions wherever it is needed be it doctor's office or clinic situation.
Besides tests for cardiac risk and chest pain currently under development, the multiparameter sensor technology will be adapted to improve care of patients with a variety of conditions.
Outside the medical field, the same technology has other potential applications in areas such as the environmental or food and beverage industries. There are useful Links to respected organisations such as the American and British Heart Associations (AHA and BHA), the European Society of Cardiology (ESC) and the British In Vitro Diagnostics Association (BIVDA) and the company brochure can be downloaded.
